Throughout 2024, pertussis cases have increased across the United States. Preliminary data show that more than six times as many cases have been reported compared to the same time in 2023.
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of pertussis cases (32,176) as of December 14, 2024. Pre-pandemic, about 10,000 cases are typically reported each year.
20% of Pertussis Cases Adjacent to I-95
Caribbean Island Vacationers Infected with Chikungunya, Dengue, Oropouche, and Zika Viruses
This year, there has been a rise in mosquito and insect-borne infections in the Caribbean, prompting many vacationers to seek preventive vaccines for chikungunya (10), dengue (105k), Oropouche virus, and Zika (16) virus diseases.
Countries like Grenada, Barbados, Saint Martin, and the Virgin Islands have reported chikungunya cases in the Caribbean region. And zika cases continue in Puerto Rico in 2024.
Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19
Administration of therapeutic- versus prophylactic-dose anticoagulation with heparins linked to lower mortality in patients hospitalized for COVID-19
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
Immediate effect of COVID-19 infection on the SymptoMScreen total score was minimal
Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023
In 2023, 3.6 percent currently had post-COVID-19 condition and 2.3 percent had activity-limiting PCC
Brief Outpatient Rehab Program Beneficial for Post-COVID-19 Condition
Statistically and clinically significant improvement seen in Short-Form 36 Physical Function Subscale scores